The present invention relates to a method for producing dendritic cells and theiruse in medicaments by genetic engineering aimed at functionally improving theirtherapeutic efficacy in the treatment of cancer, microbial infections, allergies,auto-immune diseases or organ and stem cell transplant rejection.
